Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

H3 activation for allergic rhinitis relief

Feb. 2, 2004

Novel inhibitors of ICAM/leukointegrin interaction under study at Boehringer Ingelheim

Jan. 28, 2004

Novel porphyrins with SOD activity developed at Duke University

Jan. 28, 2004

Tanabe Seiyaku scientists claim new inhibitors of alpha4 integrin-mediated cell adhesion

Jan. 27, 2004

New histamine H3 antagonists prepared and tested by Schering-Plough team

Jan. 26, 2004

Menarini presents new bradykinin B2 antagonists for inflammatory and allergic disorders

Jan. 26, 2004

New adenoviral vector for cystic fibrosis gene therapy identified

Jan. 26, 2004

First compound from Biolipox/NicOx collaboration enters phase II

Jan. 23, 2004

Novel potent CFTR activator for cystic fibrosis therapy

Jan. 23, 2004

Sumitomo and AstraZeneca form an agreement for respiratory disease treatment

Jan. 23, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...